Far Infrared Therapy - a novel treatment for AV Fistula Maturation and Maintenance

October 10, 2019

In Addenbrookes Renal Dialysis Unit, since January 2015, we have been using FIR therapy. We have demonstrated FIR therapy to help improve arterio-venous fistula (AVF) prevalence, maturation and patency, as well as blood flow rates, pain on needling and haematoma size post-needle tissue in our haemodialysis (HD).


FIR therapy is a non-invasive treatment of 40 minutes duration. It induces expression of endothelial Heme Oxygenase-1, reducing monocyte adhesions in endothelium cells and impending inflammatory responses. The theory is that this reduces further endothelial injury and dysfunction.

Tariff and efficiency

UK Renal units and renal commissioners are now focused on achieving > 80% incident and prevalent permanent vascular access rates. The tariff Renal units receive for HD has been revised and is now inextricably linked to the type of vascular access used.

This provides further economic incentive to improve AVF rates in incident and prevalent HD patients.

Inclusions

  • New patients that have just undergone AVF creation
  • AVF bruises due to infiltration from previous cannulation
  • Painful arteriovenous fistula (pain situated in the area of cannulation)

Our experience

40 patients benefited from the use of the FIR therapy


15 patients had an improvement of pain score on needling of AVF


14 patients AVF needle-site haematomas resolved quicker


11 AVFs matured with demonstrably better blood flow rates on Doppler in patients with previous AVF maturation failure


It is cost effective as we are not useing heparinoid cream to relieve bruising of the AVF, post infiltration.

Conclusions

We have found FIR therapy to be of use in the maturation of AVFs, particularly in patients with challenging access, as well as in the treatment of problems such as haematoma formation and those experiencing AVF pain during HD.

Author's:

  • Regin Lagaac


Site:

  • Cambridge University Hospitals

Presented at the 2018 UKKW Conference.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
May 23, 2025
We’re excited to announce that FIRAPY will be exhibiting at the 62nd ERA Congress in Vienna from June 4–7, 2025 ! 📍 Booth No.: X1.200 📅 June 4–7, 2025 📍 Austria Center Vienna This marks FIRAPY’s first European event since the COVID-19 pandemic , making it a special occasion for us to reconnect with partners and professionals across the continent. This year’s congress theme, “Game Changers in Nephrology,” aligns perfectly with FIRAPY’s mission to enhance dialysis care through innovative vascular access management. We look forward to seeing old friends and new collaborators who share our commitment to improving outcomes for dialysis patients. Whether you're already using FIRAPY or exploring its clinical potential, we warmly invite you to visit our booth and connect with our team.  Let’s explore how far-infrared therapy is transforming the future of vascular access—together.
May 23, 2025
From February 28 to March 1, FIRAPY was honored to participate in Dialysis Weekend 2024 in Pattaya, Thailand, at the invitation of our valued partner K2 Thailand . This annual event, hosted by the Nephrology Society of Thailand ( event site ), is a key gathering for nephrology professionals across the country. This occasion marked a milestone for K2 Thailand, as their entire dialysis sales team made their first collective public appearance alongside FIRAPY. The team’s strong presence and professionalism drew significant attention from both clinicians and industry attendees, highlighting the growing interest in FIRAPY's role in dialysis care. A special highlight of the event was the visit from Dr. Suki , a well-known figure in the international nephrology community ( WCN profile ). Dr. Suki stopped by the K2 booth to personally show support and encouragement to the team, reinforcing the collaboration and shared mission of improving vascular access outcomes for dialysis patients. 
December 2, 2024
Meet FIRAPY at Booth i1115a!
More Posts